Navigation Links
ReBuilder (RBRM) Files Complaints Against Stock Traders

CHARLES TOWN, W. Va., Feb. 23, 2012 /PRNewswire/ -- The management of ReBuilder Medical Technologies, Inc.  (Pink Sheets: RBRM) announces it has filed complaints with the U.S. Securities Exchange Commission and the The Financial Industry Regulatory Authority (FINRA) alleging certain traders of the Company shares may have engaged in the unlawful and unethical sale and trading of the Company's shares.   The firmed has hired a forensic expert to audit all stock certificates and stock trading that has occurred over the last eight (8) months.  Further information can be obtained by contacting the Company at 304-725-2202.

The company has recently experienced unexplained dips in its share price, and has uncovered instances of independent third party traders who have promised shares or sold shares, never delivered them, and refused to return their customer's money.

The company has discovered several other companies that have fallen prey to these unscrupulous independent traders.  Evidently, the traders convince their pool of customers to sell shares from prior sales and move the money to their new mark, buying on the open market, thus increasing the price, promising to give them additional shares as a reward.  The original company's shares drop when the traders sell into the market, and the scheme is repeated over and over again. 

Similar to a Ponzie scheme, these traders sometimes extort shares from companies for "awareness programs" and pay off a few of the investors who complain.  Other investors, embarrassed by being taken in when the stock price inevitably drops, just give up.

The end result for a company is a sudden increase in volume and price, followed by a drop to an even lower level than it was, and the company itself has no idea of what is happening in the background and has to deal with its original core investor's ire, and can appear incompetent.  This takes time from day to day management and makes it harder to attract new, legitimate, long term investors.

RBRM is in the DME (durable medical equipment) business of submitting claims on behalf of customers who purchase the ReBuilder device for the pain of neuropathy, peripheral neuropathy, diabetic neuropathy, and chemo induced neuropathy.  The company buys its ReBuilders directly from the manufacturer, ReBuilder Medical Inc. (

ReBuilder Medical Inc. is developing several other medical devices that RBRM is negotiating to sell to its neuropathy customers when approved by the FDA.  One of the more interesting devices is one that makes it easy and painless for the nurse to draw blood. For a 2 minute video demonstration, see

SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ReBuilder Medical Technologies, Inc. Hiring! Increases Staff by 40%
2. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
3. Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration
4. Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc.
5. Department of Justice files consent decree of permanent injunction against Ranbaxy
6. Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes
7. Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer
8. Amherst-Based Pharmaceutical Company Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants
9. Alcohol Monitoring Systems Files Appeal With Federal Circuit Court in Patent Suit
10. Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma.
11. Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES
Post Your Comments:
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):